Bellerophon Therapeutics Shares Gain 27%

Shares of Bellerophon Therapeutics Inc. (BLPH) are currently gaining nearly 27% on Wednesday morning despite no stock-related statement release from the company to drive the shares.

BLPH is currently trading at $5.16, up $1.09 or 26.59%, on the Nasdaq. For the 52-week period, the company has traded between $3.79 and $14.09. The stock has slipped nearly 62% in that period.

Bellerophon Therapeutics, a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its products include INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Biotech Stocks by Subscribing to RTT Biotech Investor.
Follow RTT